Company
Pfenex Inc. (0001478121)
Standardized SEC financial data for Pfenex Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001478121 · Pharmaceutical Preparations.
Gross margin
90.3%
Operating margin
-79.2%
Net margin
-51.0%
Revenue growth (YoY)
238.7%
Return on equity
-35.5%
Free cash flow
-$5.6M
Current ratio
6.60×
EPS (diluted)
$0.03
Ratios for fiscal year 2019, standardized from SEC filings.
Income statement
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Revenue | $60.2M | — | $14.9M | $50.3M |
| Cost of revenue | $5.3M | $5.2M | $5.0M | $4.9M |
Balance sheet
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Cash & equivalents | $81.5M | $57.9M | $56.4M | $55.8M |
| Total current assets | $86.9M | $61.5M | $63.6M | $63.8M |
Cash flow
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Operating cash flow | -$22.3M | -$21.5M | -$39.4M | -$4.1M |
| Capital expenditures | $2.9M | $2.2M | $1.5M | $1.4M |
Get 0001478121 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001478121/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001478121/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"